Vulnerability of 125I-α-conotoxin MII binding sites to nigrostriatal damage in monkey

Journal of Neuroscience

Volumn 21, Issue 15, 2001, Pages 5494-5500

  Quik, Maryka ^a   Polonskaya, Yelena ^a   Kulak, Jennifer M ^a   McIntosh, J Michael ^b  

^a PARKINSON S INSTITUTE   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Autoradiography; Dopamine; Monkeys; MPTP; Nigrostriatal system; Parkinson's disease; conotoxin MII; 3 nAChRs; 6 nAChRs

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING SITE; DOPAMINERGIC NERVE CELL; FEMALE; MALE; MONKEY; NERVE DEGENERATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; STRIATONIGRAL DEGENERATION; ANIMAL; AUTORADIOGRAPHY; BINDING COMPETITION; CEBIDAE; CHEMICALLY INDUCED DISORDER; CLASSIFICATION; CORPUS STRIATUM; DISEASE MODEL; DRUG EFFECT; HABENULA; MESENCEPHALON; METABOLISM; NERVE CELL; NERVE TRACT; PATHOLOGY; PUTAMEN; SUBSTANTIA NIGRA;

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID ISOPROPYL ESTER; ALPHA CONOTOXIN MII; ALPHA-CONOTOXIN MII; CARRIER PROTEIN; COCAINE; CONOTOXIN; DOPAMINE; DOPAMINE TRANSPORTER; DRUG DERIVATIVE; EPIBATIDINE; FUSED HETEROCYCLIC RINGS; MEMBRANE PROTEIN; NERVE PROTEIN; NICOTINIC RECEPTOR; PYRIDINE DERIVATIVE; RADIOACTIVE IODINE;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; AUTORADIOGRAPHY; BICYCLO COMPOUNDS, HETEROCYCLIC; BINDING SITES; BINDING, COMPETITIVE; CARRIER PROTEINS; COCAINE; CONOTOXINS; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HABENULA; IODINE RADIOISOTOPES; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MESENCEPHALON; NERVE TISSUE PROTEINS; NEURAL PATHWAYS; NEURONS; PARKINSON DISEASE, SECONDARY; PUTAMEN; PYRIDINES; RECEPTORS, NICOTINIC; SAIMIRI; SUBSTANTIA NIGRA;

EID: 0035413360     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.21-15-05494.2001     Document Type: Article

References (57)

1. Gene targeted knock out of the β3 neuronal nicotinic acetylcholine receptor subunit
2. Ultrastructural localization of the α4-subunit of the neuronal acetylcholine nicotinic receptor in the rat substantia nigra
3. Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases
4. Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodegenerative disorders
5. Acute intermittent nicotine treatment produces regional increases of basic fibroblast growth factor messenger RNA and protein in the tel- and diencephalon of the rat
6. Attenuation of 1-methyl-4-phenyl-1,2,3,6tetrahydropyridine-induced neurotoxicity by tobacco smoke
7. A new α-conotoxin which targets α3β2 nicotinic acetylcholine receptors
8. Brain nicotinic receptors: Structure and regulation, role in learning and reinforcement
9. 50) of an enzymatic reaction
10. 125I]-α-bungarotoxin
11. Nicotine binding in human striatum: Elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication
12. 125I]IPH, an epibatidine analog, binds with high affinity to neuronal nicotinic cholinergic receptors
13. 2 agonist N-0923 in MPTP-induced chronic hemiparkinsonian monkeys
14. Nicotine may relieve symptoms of Parkinson's disease
15. Smoking and Parkinson's disease: A dose-response relationship
16. Human neuronal nicotinic receptors
17. 3H]dopamine release from synaptosomes prepared from mouse striatum
18. Localization of nAChR subunit mRNAs in the brain of Macaca mulatta
19. Effects of smoking in patients with early-onset Parkinson's disease
20. Chronic nicotine treatment counteracts the disappearance of tyrosine-hydroxylase-immunoreactive nerve cell bodies, dendrites and terminals in the mesostriatal dopamine system of the male rat after partial hemitransection
21. Nicotinic receptors in the brain: Correlating physiology with function
22. The effects of nicotine on Parkinson's disease
23. Differential alterations in non-α7 and α7 nicotinic receptors in monkey striatum after MPTP treatment
24. α-conotoxin MII blocks nicotine-stimulated dopamine release in rat striatal synaptosomes
25. Human α6 AChR subtypes: Subunit composition, assembly, and pharmacological responses
26. Investigating levodopa-induced dyskinesias in the parkinsonian primate
27. Neuronal nicotinic receptor α 6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain
28. Involvement of α6 nicotinic receptor subunit in nicotine-elicited locomotion, demonstrated by in vivo antisense oligo-nucleotide infusion
29. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits
30. α-conotoxin AuI B selectively blocks α3 β4 nicotinic acetylcholine receptors and nicotine-evoked norepinephrine release
31. Nicotine prevents experimental parkinsonism in rodents and induces striatal increase of neurotrophic factors
32. Characterization of nicotine binding in mouse brain and comparison with the binding of α-bungarotoxin and quinuclidinyl benzilate
33. Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment
34. ST/b and DBA/2 mice differ in brain α-bungarotoxin binding and α 7 nicotinic receptor subunit mRNA levels: A quantitative autoradiographic analysis
35. Presynaptic nicotinic modulation of dopamine release in the three ascending pathways studied by in vivo microdialysis: Comparison of naive and chronic nicotine-treated rats
36. Conus peptides targeted to specific nicotinic acetylcholine receptor subtypes
37. Cigarette smoking and protection from Parkinson's disease: False association or etiologic clue?
38. Nicotinic receptor abnormalities in Alzheimer's and Parkinson's diseases
39. Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: Possible index of early neuropathology
40. Nicotinic receptors in the brain. Links between molecular biology and behavior
41. Nicotinic receptors and Parkinson's disease
42. Localization of nicotinic receptor subunit mRNAs in monkey brain by in situ hybridization
43. Differential alterations in nicotinic receptor α6 and β3 subunit messenger RNAs in monkey substantia nigra after nigrostriatal degeneration
44. 3 receptor messenger RNA and binding sites in monkey striatum and substantia nigra after nigrostriatal degeneration: Effect of levodopa treatment
45. Phenotypic characterization of an α4 neuronal nicotinic acetylcholine receptor subunit knock-out mouse
46. Selective loss of sub-populations of ventral mesencephalic dopaminergic neurons in the monkey following exposure to MPTP
47. Effects of SIB-1508Y, a novel neuronal nicotinic acetylcholine receptor agonist, on motor behavior in parkinsonian monkeys
48. Nicotinic cholinergic receptors labeled by [3H]acetylcholine in rat brain
49. 3H]acetylcholine on catecholamine and serotonin axons in brain
50. Postsynaptic nicotinic receptors on dopammergic neurons in the substantia nigra pars compacta of the rat
51. Functional α6-containing nicotinic receptors are present in chick retina
52. Location and composition of α-conotoxin MII binding nicotinic receptors in mouse brain
53. An autoradiographic study of the distribution of binding sites for the novel α7-selective nicotinic radioligand [3H]-methyllycaconitine in the mouse brain
54. 125I-α-conotoxin MII identifies a novel nicotinic acetylcholine receptor population in mouse brain
55. 125I-epibatidine
56. Presynaptic nicotinic ACh receptors